Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

NCT ID: NCT03322189

Last Updated: 2019-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-22

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current providers' standard operating procedures on pharmacogenomic testing patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pharmacogenomic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pharmacogenomic

Standard Operating Procedures on Pharmacogenomic testing and changes made to specific SOP

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be a Medical Practitioner

* Medical Doctor (MD)
* Doctor of Osteopathic (DO)
* Physician Assistant (PA)
* Advanced Practice Registered Nurse (APRN)
* Nurse Practioner (NP)
* Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion Criteria

* Government-funded insurance data cannot be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PAS Research Services

OTHER

Sponsor Role collaborator

Data Collection Analysis Business Management

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DCABM

Land O' Lakes, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAS1463

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

YouScript IMPACT Registry
NCT02191358 COMPLETED
Evaluations of CDS Systems
NCT06330740 NOT_YET_RECRUITING NA
Effectiveness of PGx Testing
NCT04120480 ACTIVE_NOT_RECRUITING NA